ABSTRACT
The use of adaptive trial designs could greatly improve the efficiency of
drug development; the incorporation of the Bayesian approach is one more
step further to this direction. Bayesian approaches provide a powerful tool
for streamlining sequential learning processes, predicting future results, and
synthesizing evidences across different resources. The resulting outcomes
using Bayesian approaches are easier to interpret and more informative for
decision making.